The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial

Journal of Veterinary Cardiology

Volumn 1, Issue 1, 1999, Pages 7-18

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; APRINDINE; BENAZEPRIL; CREATININE; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MEXILETINE; PLACEBO; POTASSIUM; QUINIDINE; UREA; VASODILATOR AGENT;

ADD ON THERAPY; ARTICLE; COMBINATION CHEMOTHERAPY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DETERIORATION; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EARLY INTERVENTION; EXERCISE TOLERANCE; FRANCE; GENERAL CONDITION IMPROVEMENT; ITALY; LONG TERM CARE; MONOTHERAPY; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZATION; RECOMMENDED DRUG DOSE; RISK REDUCTION; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; SWITZERLAND; TREATMENT DURATION; UNITED KINGDOM; UREA BLOOD LEVEL; VALVULAR HEART DISEASE;

CANIS FAMILIARIS;

EID: 0003185782     PISSN: 17602734     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1760-2734(06)70025-X     Document Type: Article

References (28)

1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Co-operative North Scandinavian Enalapril Survival Study (CONSENSUS). N Eng J Med 316 (1987) 1429-1435
2. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Eng J Med 325 (1991) 293-302
3. Blackford L., Golden L., Bright J., et al. Captopril provides sustained hemodynamic benefits in dogs with experimentally induced mitral regurgitation. Vet Surgery 19 (1990) 237-242
4. Holtz J., Munzel T., Sommer O., et al. Converting enzyme inhibition by enalapril in experimental heart failure. Nephron 55 (1990) 73-76
5. Allworth M., Church D., Maddison J., et al. Effect of enalapril in dogs with pacing-induced heart failure. Am J Vet Res 56 (1995) 85-94
6. Hamlin R., Benitz A., Ericsson G., et al. Effects of enalapril on exercise tolerance and longevity in dogs with heart failure produced by iatrogenic mitral regurgitation. J Vet Intern Med 10 (1996) 85-87
7. The COVE Study Group. Controlled clinical evaluation of enalapril in dogs with heart failure: Results of the Cooperative Veterinary Enalapril Study Group. J Vet Intern Med 9 (1995) 243-252
8. The IMPROVE Study Group. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enapril Study. J Vet Intern Med 9 (1995) 234-242
9. Ettinger S., Benitz A., Ericsson G., et al., for the LIVE Study Group. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. J Am Vet Med Assoc 11 (1999) 1573-1577
10. Morisse B., and Kersten U. Vergleichende Untersuchung mit den-ACE Hemmern Quinapril und Captopril zur Behandlung der dekompensierten Herzinsuffizienz des Hundes. Kleintierpraxis 39 (1994) 291-370
11. Hofmann V., and Kersten U. Untersuchung zur Wirksamkeit und Vertäglichkeit von Ramipril im Vergleich zu Captopril bei der Herzinsuffizienz des Hundes. Dtsch Tierärztl Wschr 103 (1996) 159-163
12. Webb R., Miller D., Traina V., et al. (1990) Benazepril. Cardiovasc Drug Rev 8 (1990) 89-104
13. Colfer H., Ribner H., Gradman A., et al. Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. Am J Cardiol 70 (1992) 354-358
14. Insel J., Mirvis D., Boland M., et al. A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin converting enzyme inhbitor, in patients with chronic congestive heart failure. Clin Pharmacol Therap 45 (1989) 312-320
15. Ribner H., Sagar K., Glasser S., et al. Long-term therapy with benazepril in patients with congestive heart failure: effects on clinical status and exercise tolerance. J Clin Pharmacol 30 (1990) 1106-1111
16. Maschio G., Alberti D., Janin G., et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Eng J Med 334 (1996) 939-945
17. King J., Mauron C., and Kaiser G. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administration to dogs. Am J Vet Res 56 (1995) 1620-1628
18. Kitagawa H., Wakamiya H., Kitoh K., et al. Efficacy of monotherapy with benazepril, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired mitral insufficiency. J Vet Med Sci 59 (1997) 513-520
19. Nakazawa M., Sawanobori T., Iwasaki K., et al. Hemodynamic effects of benazeprilat in the anesthetized dog with acute left ventricular failure. Japan J Pharmacol 56 (1991) 369-375
20. Pouchelon JL, Benazepril Veterinary Investigators Group. Treatment of heart failure in dogs with benazepril - results of European double-blind placebo controlled study. Proc. 14th ACVIM Forum. San Antonio, TX, 1996: 745.
21. Pouchelon JL, Martignoni L, Benazepril Veterinary Investigators Group. Long term clinical evaluation of benazepril in dogs with heart failure: results of European double-blind placebo-controlled study. Proc. WSAVA, BSAVA & FECAVA World Congress, Birmingham, UK 1997: 303.
22. nd edition (1999), WB Saunders, Philadelphia 883-902
23. 14C] - benazepril hydrochloride in rat, dog and baboon. Arzneim Forsch Drug Res 39 (1989) 62-67
24. Lefebvre H., Laroute V., Concordet D., and Toutain P. Effects of renal impairment on the disposition of orally administered enalapril, benazepril, and their active metabolites. J Vet Intern Med 13 (1999) 21-27
25. Cox D. Regression models and life tables. J Royal Stat Soc 34 (1972) 187-220 Series B
26. Therneau T., Grambsch P., and Fleming T. Martingale-based residuals for survival models. Biometrika 77 (1990) 147-160
27. Kalbfleisch J., and Prentice R. The statistical analysis of failure time data (1980), John Wiley & Sons Inc, New York
28. Roudebusch P., Allen T., Kuehn N., et al. The effect of combined therapy with captopril, furosemide, and a sodium-restricted diet on serum electrolyte concentrations and renal function in normal dogs and dogs with congestive heart failure. J Vet Intern Med 8 (1994) 337-342